Clinical Trial Update: Efficacy of Lapaquistat Acetate in Subjects Currently Treated With Lipid-Lowering Therapy. [Phase 3]

View source ↗

Summary

Phase 3 trial update showing the efficacy of lapaquistat acetate in subjects with Type 2 diabetes mellitus who are on lipid-lowering therapy; the study status i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Lapaquistat Acetate (lapaquistat acetate)

Snippet

Sponsor: Takeda | Conditions: Type 2 Diabetes | Phase 3 | Status: COMPLETED